BRIEF published on 08/06/2024 at 21:12, 2 years 3 months ago Evotec fournit des orientations fiscales mises à jour pour 2024 EBITDA Ajusté Prévisions De Revenus Evotec Une Croissance Durable Orientation 2024
BRIEF published on 08/06/2024 at 21:09, 2 years 3 months ago Evotec SE Updates Financial Guidance for 2024 Adjusted EBITDA Revenue Forecast Financial Guidance Evotec SE R&D Expenditure
BRIEF published on 08/06/2024 at 21:09, 2 years 3 months ago Evotec SE met à jour ses prévisions financières pour 2024 Evotec SE EBITDA Ajusté Conseils Financiers Prévisions De Revenus Dépenses De R&D
PRESS RELEASE published on 08/06/2024 at 21:07, 2 years 3 months ago Evotec provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting moderate revenue growth, reduced R&D expenditures, and adjusted EBITDA; aims for sustainable profitable growth amid market challenges Adjusted EBITDA Revenue Growth Evotec SE Guidance Update R&D Expenditures
PRESS RELEASE published on 08/06/2024 at 21:04, 2 years 3 months ago EQS-Adhoc: Evotec SE provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting revenue and EBITDA adjustments due to slower sales conversion and margin pressures, focusing on sustainable growth EBITDA Revenue Evotec SE Sustainable Growth Guidance Update
BRIEF published on 07/10/2024 at 07:35, 2 years 4 months ago Evotec and Pfizer Collaborate to Advance Drug Discovery in France Drug Discovery Metabolic Diseases Evotec Pfizer Infectious Diseases
BRIEF published on 07/10/2024 at 07:35, 2 years 4 months ago Evotec et Pfizer collaborent pour faire progresser la découverte de médicaments en France Maladies Métaboliques Evotec Découverte De Médicament Pfizer Maladies Infectieuses
PRESS RELEASE published on 07/10/2024 at 07:30, 2 years 4 months ago Evotec and Pfizer collaborate to advance drug discovery in France Evotec SE collaborates with Pfizer to focus on early discovery research for metabolic and infectious diseases in France. The multi-year agreement includes research support and potential milestones Drug Discovery Evotec SE France Pfizer Metabolic And Infectious Diseases
BRIEF published on 07/08/2024 at 14:05, 2 years 4 months ago Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz Partnership Biosimilars Evotec Sandoz Biologics
BRIEF published on 07/08/2024 at 14:05, 2 years 4 months ago Just – Evotec Biologics étend son partenariat technologique pour les biosimilaires avec Sandoz Partenariat Evotec Biosimilaires Produits Biologiques Sandoz
Published on 11/18/2026 at 00:35, 3 hours 34 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 4 hours 29 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 5 hours 9 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 6 hours 39 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 13 hours 9 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 03:15, 54 minutes ago China’s Recombinant Collagen Technology Wins the INPD Innovative Manufacturing Process Award
Published on 11/18/2026 at 03:15, 54 minutes ago La technologie chinoise du collagène recombinant remporte le prix INPD du procédé de fabrication innovant
Published on 11/18/2026 at 01:55, 2 hours 14 minutes ago WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America
Published on 11/18/2026 at 01:40, 2 hours 29 minutes ago AMPERA and Berto Announce Proposed Business Combination to Accelerate Advanced Energy Technology Development and Commercialization
Published on 11/18/2026 at 00:59, 3 hours 10 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 18:00, 10 hours 9 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 18:00, 10 hours 9 minutes ago Accor - Accor se renforce au capital de Ennismore
Published on 11/17/2026 at 17:45, 10 hours 24 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 10 hours 24 minutes ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 20 hours 29 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.